Page last updated: 2024-08-24

plerixafor and Infections

plerixafor has been researched along with Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alexander, ET; Costa, LJ; Hogan, KR; Miller, AN; Schaub, C; Shabbir, M; Stuart, RK	1

Other Studies

1 other study(ies) available for plerixafor and Infections

Article	Year
Growth factor and patient-adapted use of plerixafor is superior to CY and growth factor for autologous hematopoietic stem cells mobilization. Bone marrow transplantation, 2011, Volume: 46, Issue:4 Topics: Algorithms; Anti-HIV Agents; Antigens, CD34; Benzylamines; Cell Count; Cyclams; Cyclophosphamide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Infections; Male; Middle Aged; Precision Medicine; Retrospective Studies; Transplantation, Autologous	2011

Article

Year

Growth factor and patient-adapted use of plerixafor is superior to CY and growth factor for autologous hematopoietic stem cells mobilization.

Bone marrow transplantation, 2011, Volume: 46, Issue:4

Topics: Algorithms; Anti-HIV Agents; Antigens, CD34; Benzylamines; Cell Count; Cyclams; Cyclophosphamide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Infections; Male; Middle Aged; Precision Medicine; Retrospective Studies; Transplantation, Autologous

2011